NYSE:TEVA   Teva Pharmaceutical Industries Limited
TEVA’s innovation outlook is neutral based on a current score of 56 out of 99, outperforming sector average. Insiders sentiment is positive. TEVA is an Average Performer in terms of sustainability. Over the past 4 quarters TEVA beat earnings estimates 3 times.
For more analysis and articles visit our website.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。